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Abstract
Here, we show that the eukaryotic translation elongation factor 1 gamma (eEF1c) physically interacts with the RNA
polymerase II (pol II) core subunit 3 (RPB3), both in isolation and in the context of the holo-enzyme. Importantly, eEF1c has
been recently shown to bind Vimentin mRNA. By chromatin immunoprecipitation experiments, we demonstrate, for the first
time, that eEF1c is also physically present on the genomic locus corresponding to the promoter region of human Vimentin
gene. The eEF1c depletion causes the Vimentin protein to be incorrectly compartmentalised and to severely compromise
cellular shape and mitochondria localisation. We demonstrate that eEF1c partially colocalises with the mitochondrial marker
Tom20 and that eEF1c depletion increases mitochondrial superoxide generation as well as the total levels of carbonylated
proteins. Finally, we hypothesise that eEF1c, in addition to its role in translation elongation complex, is involved in
regulating Vimentin gene by contacting both pol II and the Vimentin promoter region and then shuttling/nursing the
Vimentin mRNA from its gene locus to its appropriate cellular compartment for translation.
Citation: Corbi N, Batassa EM, Pisani C, Onori A, Di Certo MG, et al. (2010) The eEF1c Subunit Contacts RNA Polymerase II and Binds Vimentin Promoter
Region. PLoS ONE 5(12): e14481. doi:10.1371/journal.pone.0014481
Editor: Thomas Preiss, Victor Chang Cardiac Research Institute, Australia
Received July 15, 2010; Accepted December 5, 2010; Published December 31, 2010
Copyright:  2010 Corbi et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported by Paul Blumel Foundation; by Associazione Italiana per la Ricerca sul Cancro (AIRC) projects IG 2009 and IG 5697; by Telethon
project GGP07177; Progetto PRIN 2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the
manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: passananti@ifo.it
Introduction
The RNA polymerase II (pol II) core enzyme consists of at least
twelve different subunits that associate with several mediator
proteins and general transcription factors to form the holoenzyme
complex [1-4]. We had previously cloned two subunits of the
human pol II enzyme, RPB11 (UniProtKB: P52435) and RPB3
(UniProtKB: P19387) [5–6]. RPB3 and RPB11 form a heterodi-
mer that is reminiscent of the a subunit homodimer of bacterial
RNA polymerase that is involved in promoter recognition. The
RPB3/RPB11 heterodimer plays a central role in the interaction
between pol II and the mediator complex, suggesting functional
conservation from prokaryotes to eukaryotes [7]. Using the RPB3
subunit as bait in a series of yeast two-hybrid experiments, we
defined RPB3 involvement in tissue-specific transcription. We
demonstrated that RPB3 directly contacts several transcription
factors, including ATF4, a member of the ATF/CREB family and
Myogenin, a member of the MyoD gene family [8–9]. In addition,
we have recently shown that RPB3 is retained/stored in the
cytoplasm interacting with CCHCR1, the psoriasis vulgaris
candidate gene product [10].
Here, we show, for the first time, that RPB3, alone and
complexed in pol II, interacts with the Eukaryotic Elongation
Factor 1 subunit gamma (eEF1c) (UniProtKB: P26641) that is a
part of eEF1 complex. Eukaryotic elongation factor 1 (eEF1) is a
macromolecular complex that catalyses the transfer of aminoacyl-
tRNAs to ribosomes [11]. In higher eukaryotes, eEF1 consists of
three or four subunits, eEF1a, eEF1b, eEF1c and eEF1d,
respectively renamed eEF1A, eEF1Ba, eEF1Bc and eEF1Bd
[11–12]. For the purposes of simplicity in this article we use the
older nomenclature (eEF1c). The eEF1a subunit of EF1 binds
aminoacyl-tRNA in a GTP-dependent manner and the resulting
ternary complex binds to the ribosome [13]. Following aminoacyl-
tRNA binding to the ribosomal A site via a codon-anticodon
interaction, GTP is hydrolysed to GDP. Subsequently, GDP
remains bound to eEF1a and eEF1b acts as nucleotide exchange
factor, regenerating eEF1a-GTP for the successive elongation
cycle. The physiological role of the eEF1c subunit in this context is
still not well defined. There is some evidence that eEF1c
stimulates, but is not required for, the nucleotide exchange activity
of eEF1b [12]. Indeed, eEF1c appears dispensable for translation,
its absence doesn’t seem to affect global rate of translational
elongation. Instead eEF1c depletion in Saccharomyces cerevisiae
provides resistance to oxidative stress [14]. A role of eEF1c in
the oxidative stress response pathways is justified by the presence
in the N terminus of eEF1c of a conserved sequence resembling
the glutathione-binding region of the theta class of Glutathione S-
transferases (GST) enzymes, which is involved in the detoxification
of oxygen radicals [15]. The over-expression of eEF1c, described
in several tumours, influences tumour aggressiveness presumably
by altering the redox balance [12,16]. Nevertheless, multiple/
additional roles for eEF1c are emerging, some of which can be
regulated by phosphorylation driven by several protein kinases
[17–18]. eEF1c displays an affinity for membrane and cytoskel-
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of the EF1 complex to the cytoskeleton [12,19–21]. Interestingly,
Al-Maghrebi et al. (2002) showed in studies in vitro and in vivo
that eEF1c binds the 39UTR of Vimentin (UniProtKB: P08670)
mRNA, demonstrating for the first time the RNA-binding
properties of eEF1c [22]. In addition, human eEF1c was recently
identified in a proteomic screen as a member of the pre-mRNA 39
end cleavage complex [23]. To further reinforce a role for eEF1c
in RNA metabolism, Fan et al. demonstrated in Drosophila that
eEF1c activity is required for the viability of both the whole
animal and individual cells, emphasising that recessive lethality
occurs during early larval development. This observation is
consistent with an extensive maternal contribution of the RNA
and protein to the embryo [18]. In this scenario eEF1c could
contribute to the anchoring and translation of a set of mRNAs that
are preferentially translated on cytoskeletal- or membrane-bound
ribosomes, such as Vimentin mRNA.
Vimentin is the major intermediate filament protein involved in
cell structural support, signal transduction and organelle position-
ing [24]. Morris et al. (2000) demonstrated that misdirecting
Vimentin mRNA it is possible to alter cell morphology and
motility [25]. The replacement of the Vimentin 39 untranslated
region (39UTR), where both eEF1c and Hax1 proteins bind, with
the bactin 39UTR resulted in the misdirection of Vimentin
mRNA. In particular, Vimentin has been recently reported to
have a regulatory role in supporting the morphology, organization
and function of mitochondria [26]. Here, we show that eEF1c
interacts with pol II and stays on/binds Vimentin gene promoter,
where eEF1c may start to perform its function/s. In addition, we
show that eEF1c partially localises within mitochondria and that
eEF1c depletion induces the incorrect compartmentalisation of
Vimentin protein, resulting in a severe compromise of cellular
shape and mitochondria localisation. We show that eEF1c
depletion increases mitochondrial generation of superoxide and
total carbonylated proteins. Finally, we hypothesise that eEF1c
plays an additional role in RNA metabolism.
Results
The RPB3 subunit was used as bait (fig. 1B) in a series of yeast
two-hybrid experiments to isolate RPB3-interacting proteins from
a human skeletal muscle cDNA library. Of an estimated 2.5610
6
transformants, 30 clones proliferated on media lacking histidine
and adenine as well as stained positive for b-galactosidase. Several
clones were isolated for further characterisation [6,9–10] and the
clone encoding for the ubiquitous eukaryotic translation elonga-
tion factor 1 gamma subunit (eEF1c) (fig. 1B) was selected for
further study. The specificity of the RPB3/eEF1c interaction was
confirmed in a two-hybrid assay co-transforming eEF1c with
either RPB3, or an empty vector (pGBKT7) and a Lamin control
vector (pLAM). This assay demonstrated that RPB3 interacts only
with eEF1c (fig. 1A). The eEF1c cDNA fragment isolated in this
yeast two-hybrid screen spanned almost the entire open reading
frame, missing only seven amino acid residues in the extreme
amino terminal portion. A full length open reading frame was
isolated and cloned in the myc-tagged expression vector pCS2-MT
‘‘myc- eEF1c’’ (fig. 2C and M&M section).
Co-immunoprecipitation experiments were performed to pro-
vide evidence that RPB3 also associates with eEF1c in mammalian
cells. Expression vectors for flag-tagged RPB3 (flag-RPB3) and
myc- eEF1c were co-transfected into HeLa cells. Immunoprecip-
itation using a flag-monoclonal antibody followed by western blot
analysis of the precipitates with a myc-monoclonal antibody
clearly demonstrates co-immunoprecipitation of myc-eEF1c with
flag-RPB3 (fig. 1C). These co-immunoprecipitation data were
further confirmed performing the reciprocal experiment. EGFP-
tagged RPB3 (EGFP-RPB3) efficiently co-immunoprecipitated
with myc-eEF1c (fig. 1D and fig. 2B).
RPB3 and eEF1c protein regions required for mutual
interaction
Co-immunoprecipitation experiments were performed to deter-
mine the RPB3 protein region responsible for binding eEF1c.
HeLa cells were co-transfected with myc-eEF1c and a series of
RPB3 deletion mutants fused to the EGFP protein (fig. 2A) [10].
Immunoprecipitation was performed with an anti-myc monoclo-
nal antibody and analysed by western blot using an anti-EGFP
monoclonal antibody. A region 62 amino acids long at the amino
terminal portion of the RPB3 protein, which corresponds to the a-
like-1 domain, is required for myc-eEF1c interaction (fig. 2B).
Then, to better characterise this interaction, we decided to identify
the eEF1c protein region responsible for RPB3 binding. Thus, co-
immunoprecipitation experiments in HeLa cells co-transfected
with flag-RPB3 and myc-eEF1c and a series of its deletion mutants
were performed (fig. 2C–D). Immunoprecipitation using an anti-
flag monoclonal antibody followed by western blot analysis with an
anti-myc monoclonal antibody demonstrated that binding was
greatly affected when a region 40 amino acids long between
residue 137 to residue 177 was deleted (fig. 2C).
eEF1c interacts with pol II and binds Vimentin gene
promoter region
RPB3, one of the essential subunits of pol II, has most of its
surface buried in interactions with other pol II subunits [27]. Yeast
two-hybrid and co-immnuprecipitation assay demonstrated that
the RPB3 protein alone is able to contact eEF1c. To verify the
capability of eEF1c to contact the pol II enzyme, the total lysate
from HeLa cells over-expressing myc-eEF1c was immunoprecip-
itated with a polyclonal antibody against RPB1, the largest subunit
of pol II (fig. 3A). Western blot analysis of the immunoprecipitates
using an anti-myc monoclonal antibody clearly demonstrated the
presence of myc-eEF1c in the pol II complex. The endogenous
eEF1c protein was also able to co-immunoprecipitate with pol II.
The total lysate from HeLa cells was immunoprecipitated with an
anti-RPB1 polyclonal antibody followed by western blot analysis
using the anti-eEF1c polyclonal antibody, indicating the presence
of eEF1c in the pol II immunoprecipitated complex (fig. 3B). To
verify the presence and possibly the relative concentration of
eEF1c in the nuclear compartment of HeLa cells, western blot
analysis was performed using cytoplasmic and nuclear fractions.
eEF1c was present in both compartments in a manner resembling
the pattern showed by Hax1, a principally mitochondrial, RNA-
binding protein that binds Vimentin mRNA [22]. The quality of
the HeLa cell fractionation was tested using anti-Sp1 and anti-a-
tubulin antibodies. In summary, we showed that eEF1c binds
RPB3 and that it co-immunoprecipitates with pol II. In addition,
eEF1c was recently shown to bind 39UTR of Vimentin mRNA
[22], this region is required to perinuclear Vimentin mRNA
localization [28]. The affinity of eEF1c for Vimentin mRNA and
its ability to be included in pol II complexes suggested the
possibility that eEF1c also stays on Vimentin gene promoter
region. Chromatin immunoprecipitation experiments (ChIP) were
performed to verify this possibility. In HeLa cells, eEF1c is able to
stay efficiently and specifically on the chromosomal locus located
approximately 200 bp upstream of the Vimentin gene mRNA
start site (fig. 3D). The specificity of DNA amplification was
checked using the Thymidine Kinase (TK) and DNA-pol b human
eEF1c Affects Vimentin Fate
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were performed on human neuroblastoma SY5Y cells (fig. S1A).
eEF1c depletion influences Vimentin protein localization
We then wanted to determine if the ability of eEF1c to bind to
and to compartmentalise Vimentin mRNA could influence the
localisation of the Vimentin protein. HeLa cells that were
untreated, treated with a scrambled siRNA-Control and treated
with a siRNA specific for eEF1c were analysed in immunofluo-
rescence experiments using an anti-Vimentin antibody (fig. 4A). In
HeLa cells depleted of eEF1c, the Vimentin protein is mis-
localised, appearing to accumulate along the cell membrane and
the shapes of the HeLa cells are less organised and thick than in
cells expressing eEF1c (fig. 4A). The efficiency of eEF1c siRNA
depletion was monitored by western blot analysis (fig. 4B).
eEF1c partially co-localizes with mitochondria
Vimentin, an intermediate filament, is involved in structural
support, signal transduction and organelle positioning. Recently,
Vimentin has been shown to participate in determining mito-
chondrial morphology and organisation, with its knockdown
resulting in mitochondrial fragmentation, swelling and disorgani-
sation [26]. To verify if eEF1c could influence Vimentin
mitochondrial function/s, we enquired the eEF1c mitochondrial
localisation. Western blot analysis indicates the presence of eEF1c
in mitochondria-enriched HeLa cell extracts (fig. 4C). The anti-
Hax1 monoclonal antibody was used to verify the quality of the
cellular fractionation. Hax1 predominantly localises to mitochon-
dria and has been shown to be able to bind Vimentin mRNA [22].
To further verify the mitochondrial localization, a rabbit
polyclonal antibody against Tom20, a well-established mitochon-
drial marker [29], was used in a dual-label immunofluorescence
assay in HeLa cells along with the anti-eEF1c antibody. Extensive
co-localisation between endogenous eEF1c and Tom20 is revealed
by the merged-colour image (fig. 4D). In addition, in figure S1B
we show, in HeLa cells, the eEF1c mitochondrial localization by
merge of mitochondrion-selective dye MitoTracker (red) and
indirect immunofluorescence of endogenous eEF1c (green).
eEF1c siRNA depletion induces mitochondrial
fragmentation and increases cellular levels of superoxide
Using indirect immunofluorescence with both the anti-Tom20
polyclonal antibody and anti-Vimentinmonoclonal antibody,HeLa
cells treated with eEF1c-specific siRNA show clear mitochondrial
fragmentation, swelling and disorganisation (fig. 5A). The same
effect was observed in SY5Y neuroblastoma cells (fig. S1C).
In order to investigate possible effects of eEF1c depletion on
both transcription and translation, we performed Real time RT-
PCR on Vimentin transcript and methionine/cystein S
35 total
protein incorporation experiments. Histograms presented in
figure 5B shows only a slight decrease of Vimentin mRNA levels
upon eEF1c knockdown in HeLa cells. Equivalent results were
obtained upon eEF1c siRNA in SY5Y cell line (data not shown).
Then we investigated the effect of eEF1c depletion on global
translation. To this end we performed methionine/cystein S
35
incorporation experiments followed by a western blot in both
HeLa and SY5Y cells (fig. 5C and fig. S1D). In our experimental
conditions eEF1c-specific siRNA depletion does not affect global
Figure 1. RPB3 interacts with eEF1c.A : Yeast two hybrid assay: AH109 yeast cells were co-transformed with the indicated constructs and plated
onto SD media lacking leucine and tryptophan (-LW) to verify the expression of both bait (W
+) and prey (L
+) plasmids, or onto media lacking leucine,
tryptophan, histidine and adenine (-LWHA) to examine the interaction between bait and prey proteins. B: Schematic representation of full-length
proteins of both bait (RPB3) and prey (eEF1c). C: Whole cell extracts of HeLa cells transfected with either myc-eEF1c or flag-RPB3 and myc-eEF1c were
immunoprecipitated with the anti-flag monoclonal antibody and the co-immunoprecipitation was analysed by western blot using the anti-myc
monoclonal antibody. The myc-eEF1c signal is above the heavy chain Ig band. D: Whole cell extracts of HeLa cells transfected with either myc-eEF1c
or with myc-eEF1c and EGFP-RPB3 were immunoprecipitated with the anti-myc monoclonal antibody and the co-immunoprecipitation was analysed
by western blot using the anti-EGFP monoclonal antibody. The EGFP-RPB3 signal is above the heavy chain Ig band.
doi:10.1371/journal.pone.0014481.g001
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Vimentin translational level.
To determine if eEF1c knockdown also induces oxidative stress,
the oxidation levels of the cells were evaluated through the amount
of carbonylated proteins. The total protein carbonylation pattern
was visualised by western blot with an anti-DNP antibody in HeLa
cells that were untreated, treated with the scrambled siRNA-
control or treated with the siRNA specific for eEF1c (fig. 5D).
HeLa cells depleted of eEF1c show a consistent increase in the
levels of carbonylated proteins and a concomitant decrease in the
levels of the Tom20 protein. The same effect on total protein
carbonylation pattern was observed in SY5Y neuroblastoma cells
(fig. S1E). In addition, a significant increase in the mitochondrial
superoxide was detected in eEF1c-depleted HeLa cells, using
MitoSOX fluorescent probe (fig. 5E).
Materials and Methods
Yeast two-hybrid selection
For two-hybrid screening, the complete open reading frame
(ORF) of human RPB3 was cloned into the BamHI restriction site
of the vector pGBKT7 (Clontech, Palo Alto, CA) in frame with the
GAL4 binding domain (BD) and used to screen a human skeletal
muscle cDNA library (Clontech) as previously described [9]. Yeast
strain AH109 bearing UASg-His3, UASg-ADE2 and UASg-LacZ
as reporter genes, was co-transformed as previously described [10].
The recovered library-derived plasmids were analysed as candi-
date binding partners.
Constructs
Full-length human Flag-RPB3 (vector-pCMV-Tag2A) (Strata-
gene), EGFP-RPB3 (vector-pEGFP-N) (Clontech), and RPB3
deletion mutants were generated by the use of PCR amplification
and/or sub-cloning [10]. The myc-tagged pCS2-eEF1c (Myc-
eEF1c) construct and its derived deletion mutants Myc-eEF1c-a
and Myc-eEF1c–b and Myc-eEF1c-c were generated by PCR
amplification.
Co-immunoprecipitation and immunoblotting
Whole-cell extracts were prepared in lysis buffer (50 mM Tris-
HCl pH 7.5, 250 mM NaCl, 5 mM EDTA, 0,1% Triton X-100)
supplemented with a proteinase inhibitor cocktail (CompleteTM,
Roche). Immunoprecipitation assays were performed following
standard procedure, using the following antibodies: agarose-
covalently attached anti-flag monoclonal M2 (Sigma), anti-myc
monoclonal antibody (9E10 clone, hybridoma-conditioned medi-
Figure 2. RPB3 and eEF1c protein regions required for mutual interaction. A: Schematic representations of the EGFP-tagged full-length
RPB3 and its derived deletion mutants. The construct designation and binding activity (to eEF1c) are indicated on the right side. B: Cell lysates from
HeLa cells co-transfected with each indicated construct (EGFP, EGFP-RPB3 and EGFP-RPB3 nested deletion-mutants) and myc-eEF1c were
immunoprecipitated with the anti-myc antibody. Immunoprecipitated samples were analysed by western blot using the anti-EGFP monoclonal
antibody to identify RPB3 domains involved in myc-eEF1c interaction (top). The total cell lysates were immunoblotted to verify the correct expression
of the transfected molecules (bottom). The asterisks mark the signal corresponding to the RPB3-a mutant (lane 3), partially covered by the heavy
chain Ig band (top) and a non-specific band (bottom). C: Schematic representations of myc-tagged full-length eEF1c and its derived deletion
mutants. Constructs designation and binding activity (to RPB3) are indicated on the right side. D: Cell lysates from HeLa cells co-transfected with flag-
tagged RPB3 and myc-eEF1c deletion constructs were immunoprecipitated with the anti-flag monoclonal antibody. Co-immunoprecipitation was
analysed by western blot using the anti-myc monoclonal antibody (left). The total cell lysates were immunoblotted to verify the correct expression of
all the transfected molecules (right).
doi:10.1371/journal.pone.0014481.g002
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Immuno-precipitated proteins were eluted from beads by boiling
in LDS Sample Buffer for 10 minutes, followed by electrophoresis
on NuPAGE H Bis-Tris Gel System (Invitrogen). Western blots
were prepared by standard procedures, probed using appropriate
dual immuno-staining and visualised by chemiluminescence (ECL
plus; GE Healthcare) according to the manufacturer’s instructions.
For the biochemical analysis, the following antibodies were used:
anti-myc monoclonal antibody (9E10 clone, hybridoma-condi-
tioned medium), anti-flag rabbit polyclonal antibody (Sigma), anti-
pol II rabbit polyclonal antibody (Santa Cruz), anti-eEF1c rabbit
polyclonal (Bethyl Laboratories Inc.) and anti-GFP monoclonal
antibody (Clontech).
Immunofluorescence- Immunofluorescence was performed to detect
the Vimentin and Tom20 proteins in HeLa and SY5Y cells. The
cells were transfected with siRNA Dharmacon and 72 hours later
were fixed/permeabilised in 3:7 methanol-acetone for 20 min at
220uC or fixed with 4% paraformaldheyde for 10 min at R.T.
and then permeabilised with 0.2% Nonidet P-40 in phosphate-
buffered saline (PBS) for 10 minutes. To detect the expression of
endogenous Vimentin and/or Tom20, the cells were incubated for
1 hour at room temperature with a 1:50 dilution (in PBS
containing 2% BSA) of mouse monoclonal anti-Vimentin (Dako)
or with a 1:200 dilution of rabbit polyclonal anti-Tom20 antibody
(Santa Cruz). Immunoreactivity was visualised using an Alexa-
Fluor594-conjugated anti-mouse IgG (Molecular Probes, Invitro-
gen) secondary antibody or an Alexa-Fluor488-conjugated anti-
rabbit IgG (Molecular Probes, Invitrogen) secondary antibody. To
detect co-localisation of eEF1c and Tom20 proteins, HeLa cells
were fixed in 4% paraformaldehyde for 10 min at R.T.,
permeabilised with 0.2% Nonidet P-40 in PBS for 10 minutes
and incubated overnight with the anti-eEF1c mouse monoclonal
antibody (1:50 dilution) (Abnova Corporation), plus one additional
hour together with anti-Tom20 rabbit polyclonal antibody.
To label mitochondria, HeLa cells were incubated with 250 nM
of MitoTrackerH Red CMXRos M7512 (Invitrogen) according to
the manufacture’s instructions. Once the mitochondria were
labelled, the cells were fixed and incubated overnight with the
anti-eEF1c mouse monoclonal antibody, as above.
Mitochondrial superoxide detection
Mitochondrial superoxide generation was detected using
MitoSOX
TM Red (Molecular Probes, Invitrogen), a specific
mitochondrial superoxide indicator of reactive oxygen species
(ROS), according to manufacturer protocol. Briefly, HeLa cells
were incubated in 5 mM MitoSOX in PBS for 10 min followed by
staining with Hoecst (4 mg/ml). After incubation, cells were
washed in PBS and examined under inverted microscope (LEICA
FW4000). For semiquantification of MitoSOX fluorescence, five
non adjacent images were taken for each group under identical
Figure 3. eEF1c interacts with pol II and binds Vimentin gene promoter region. A: Total lysates from HeLa cells transfected with either an
empty control vector or myc-eEF1c were immunoprecipitated with the anti-pol II polyclonal antibody and analysed by western blot using the anti-
myc monoclonal antibody. B: Whole extracts from HeLa cells immunoprecipitated with the anti-pol II polyclonal antibody. Co-immunoprecipitation
was analysed by western blot using the anti-eEF1c polyclonal antibody. The eEF1c signal is specifically detected in the pol II I.P. sample (below the
heavy chain Ig band). The I.P. control was performed with normal rabbit serum. Total cell lysates and immunopreciptated samples were
immunoblotted with the anti-pol II polyclonal antibody. C: Western blot analysis of the cytoplasmic and nuclear fractions derived from HeLa cells. The
blot was incubated with the anti-eEF1c polyclonal antibody to determine the subcellular localization of eEF1c. To verify fractionation quality, the
same extracts were incubated with the anti-Hax1, anti-Sp1 and anti-alpha-tubulin antibodies. D: eEF1c stays on Vimentin promoter at the
endogenous chromosomal site. Chromatin immuno-precipitation was performed in HeLa cells using the anti-eEF1c rabbit polyclonal antibody/
protein G-agarose beads or only protein G-agarose beads as a control (no-Ab). Immuno-precipitates from each sample were analysed by PCR
performed using primers specific for the human Vimentin promoter. The DNA-pol b and thymidine kinase human promoters were also amplified. A
sample representing linear amplification of the total input chromatin (input) was included in the PCR as a control.
doi:10.1371/journal.pone.0014481.g003
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each image were counted. Data from a total of three independent
experiments were analysed. MitoSOX fluorescence was quantified
using ImageJ analysis software and normalized for cell counts.
Cell culture and transfections
Human HeLa cells (ATCC, CCL-2) were grown in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with 10% foetal
bovine serum (FBS; Gibco). Human SY5Y neuroblastoma cells
(ATCC, CRL-2266) were grown in DMEM supplemented with
15% foetal bovine serum. All cell cultures were maintained at
37uC in a humidified atmosphere of 5% CO2. Transient
transfections were performed using Lipofectamine or Lipofecta-
mine 2000 reagents (Invitrogen), according to the manufacturer’s
instructions. The total amounts of transfected DNA were equalised
using empty vectors.
The siRNA-mediated interference experiments for eEF1c
expression were performed by transfecting SMART pool-specific
or non-specific control pool double-stranded RNA oligonucleo-
tides (Dharmacon) using Lipofectamine 2000.
Sub-cellular fractionation
HeLa cells (,6610
6) were rinsed three times with ice-cold PBS,
harvested, and centrifuged at 1200 g for 2 min at 4uC. The cell
pellet was lysed in 200 ml of buffer A (50 mM Tris-HCl pH 7.5,
5 mM EDTA, 10 mM NaCl, 0.05% NP40, 0.5 mM DTT,
protease inhibitor cocktail) and centrifuged for 30 seconds at
15000 g at 4uC. The supernatant was saved as the cytoplasmic
fraction. The pellet was rinsed two times with buffer A. The
nuclear pellet was lysed in 65 ml of buffer B (20 mM Hepes
pH 7.9, 1.5 mM MgCl2, 0.2 mM EDTA, 420 mM NaCl, 25%
glycerol, protease inhibitor cocktail), incubated on ice for 30 min
and centrifuged for 10 min at 15.000 g at 4uC. The supernatant
was saved as the nuclear fraction. The mitochondrial fraction was
purified from HeLa cells (,2610
7) using the Qproteome
Mitochondria Isolation Kit (Qiagen) according to the manufac-
turer’s instructions. All fractions were reconstituted to a final
concentration of 1X LDS Sample Buffer and analysed by the
NuPAGE H Bis-Tris Gel System (Invitrogen). The purity of the
cytosolic, nucleic and mitochondrial fractions, was determined by
probing with anti-a-tubulin monoclonal antibody (Merck4Bios-
ciences), anti-Sp1 monoclonal antibody (Santa Cruz) and anti-
Hax1 monoclonal (BD Biosciences)/anti-Tom20 polyclonal (Santa
Cruz) antibodies, respectively.
Chromatin Immunoprecipitation (ChIP) assay
Chromatin Immunoprecipitation assay was performed as
previously described [30]. Briefly, HeLa or SY5Y cells (,2610
7)
were cross-linked with 1% formaldehyde for 10 min at 37uC and
lysed. The cell lysate was sonicated on ice, resulting in DNA
Figure 4. eEF1c partially co-localizes with mitochondria and its depletion influences Vimentin protein localisation. A: Indirect
immunofluorescence of Vimentin, obtained with the monoclonal antibody anti-Vimentin, in HeLa cells: untreated, treated with siRNA-Control and
eEF1c-depleted by specific siRNA. B: Western blot analysis of HeLa cells (from panel A): untreated and treated with either siRNA-Control or with eEF1c
specific siRNA. C: Western blot analysis of HeLa cell total lysate and the enriched mitochondrial fraction. The quality of mitochondrial enriched
fraction was monitored using the anti-Hax1 monoclonal antibody and the anti-Tom20 rabbit polyclonal antibody. D: Dual-label indirect
immunofluorescence performed in HeLa cells with the anti-Tom20 rabbit polyclonal antibody and the anti-eEF1c monoclonal antibody to visualise
the immunolocalisation of endogenous eEF1c (green) and Tom20 (red). Extensive co-localization (yellow) between eEF1c and Tom20 is visualised by
the merged-colour image. On the right side, the same immunofluorescences are presented at a higher magnification (1006).
doi:10.1371/journal.pone.0014481.g004
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chromatin from each sample were immunoprecipitated over night
with the anti-eEF1c rabbit polyclonal antibody (Bethyl Laborato-
ries, Inc.). Immunoprecipitation with no specific immunoglobulins
(Santa Cruz) was performed as a negative control. DNA
representing 0.005% of the sonicated chromatin solution (input)
and 10% of the immunoprecipitated sonicated chromatin solution
were amplified using the human Vimentin specific primers, hVIM
forward (59-CCGCAGCCCCGAGACCGCCGCGCA-39) and
hVim reverse (59-GTCCCGTTACTTCAGCGCTGGGCT-39),
the human thymidine kinase specific primers, hTK forward (59-
GCCCCTTTAAACTTGGTGGGCGG-39) and hTK reverse
(59-TTGCGCCTCCGGGAAGTTCACG-39), the DNA poly-
merase b specific primers, hPolb forward (59-TCAGAATCAA-
GATCGCACTCCCGT-39) and hPol b reverse (59-GCGCT-
TGTTGTGACGTCACGCGTCC-39). PCR conditions were: 30
cycles at 95uC for 45 s, 60-67uC for 30 s, 72uC for 30 s and a final
extension at 72uC for 5 min.
RNA extraction, retrotranscription and real-time PCR
Total RNA was extracted from HeLa cells transfected with
siRNA Dharmacon using TRIzol reagent according to the
manufacturer’s instructions (Invitrogen). 2 mg of RNA was reverse
transcribed using oligo (dT) 12–18 primers and Superscript II
(Invitrogen) in a final volume of 20 ml, at 42uC for 50 min. A real-
time PCR assay was performed in a 96-well format using the ABI
Prism 7000 Sequence Detection System (Applied Biosystems,
Foster City, CA). To obtain the vimentin or eukaryotic translation
elongation factor 1 gamma gene expression rate the amount of
target genes were normalized to that of the housekeeping gene
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Primers
and probes for VIM or eEF1c (target genes) and for GAPDH
(housekeeping gene) were purchased as TaqMan Gene Expression
Assays (Applied Biosystems). The PCR mixtures containing the
cDNA template, the TaqMan Universal PCR master mix (AB)
and the primers/probe were analysed in triplicate using standard
Taqman conditions. The results were analyzed using Applied
Figure 5. Analysis of eEF1c depletion. A: Indirect immunofluorescence obtained with the anti-Tom20 rabbit polyclonal and the anti-Vimentin
monoclonal antibody in HeLa cells treated with siRNA-Control or with siRNA-eEF1c. On the right side a higher magnification image of eEF1c-depleted
HeLa cells focusing on the formation of mitochondrial dysfunctional clusters. B: Real time RT-PCR analysis of the eEF1c (left) and Vimentin (right)
mRNAs in HeLa cells (siRNA-Control and siRNA-eEF1c). The gene expression ratio between eEF1c and GAPDH and between Vimentin and GAPDH are
shown as means 6 SD from three independent experiments performed in triplicate. C: The global protein synthesis of HeLa cells, transfected with
either siRNA-Control or siRNA-eEF1c and supplemented with S
35 labelled methionin and cystein, was visualized by autoradiography of the total
protein lysates blotted to nitrocellulose membrane. Then the same membrane was incubated with the anti-eEF1c rabbit polyclonal and the anti-
Vimentin mouse monoclonal antibodies. Anti-b-actin monoclonal antibody was used to normalise the amount of protein loaded on the gel. D:
Induced carbonylation pattern (oxidation level) of HeLa cells: untreated, treated with either siRNA-Control or siRNA-eEF1c. The total protein
carbonylation pattern was visualised by western blot with the anti-DNP antibody. Depletion of eEF1c by siRNA was monitored using the anti-eEF1c
rabbit polyclonal antibody. The levels of Tom20 protein were monitored using the anti-Tom20 polyclonal antibody. Anti-alpha-tubulin monoclonal
antibody was used to normalise the amount of protein loaded on the gel. E: Representative florescence images of HeLa cells treated with either
siRNA-Control or siRNA-eEF1c (top). The cellular level of superoxide was visualized by the MitoSOX (red) mitochondrial Superoxide Indicator staining.
Nuclei were stained with Hoechst (blue). Histogram reporting fold of increase of MitoSOX fluorescence of siRNA-eEF1c treated cells (lane 2) versus
siRNA-Control treated cells (lane 1), shown as means 6 SD from three independent experiments (bottom).
doi:10.1371/journal.pone.0014481.g005
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between VIM or eEF1c and GAPDH mRNAs expression.
S35-Labeling Experiments
HeLa or SY5Y cells were transfected with siRNA Dharmacon
and 72 hours later were starved for 1 hour and 30 min in DMEM
lacking Met/Cys. [S
35]Met/[S
35]Cys (PerkinElmer Life Sciences)
were added to the medium (44 mCi/ml; 1 Ci/37 GBq), and the
cells were incubated for further 3 hours. The cell lysates were then
subjected to SDS-PAGE, transferred to a nitrocellulose membrane
and detected by autoradiography. The membrane was then
incubated with the following antibodies: the anti-Tom20 rabbit
polyclonal, the anti-Vimentin mouse monoclonal (Sigma) and the
anti-b-actin monoclonal.
Protein Carbonyl Assay
Protein carbonyl levels, an index of protein oxidation, were
determined by using the Oxyblot Protein Oxidation Detection kit
(Chemicon) according to the manufacturer’s instructions. Briefly,
15–20 mg of protein were diluted to a final concentration of 6%
SDS and incubated with 2,4-dinitrophenylhydrazine (DNPH) for
15 min. Then, samples were neutralized, electrophoresed on
NuPage gels (Invitrogen), transferred and blocked. The membrane
was first incubated with the anti-DNP rabbit polyclonal antibody
(1:150), then stripped and subsequently reprobed for anti-a-
tubulin and anti-Tom20 antibodies.
Discussion
The novelty presented in this manuscript is that eEF1c,a
subunit of the elongation factor-1 complex, interacts with pol II
and binds Vimentin gene promoter, where eEF1c may start to
play its function/s. We initially isolated eEF1c in a yeast two-
hybrid screening using RPB3, the a-like RNA polymerase II core
subunit, as bait. The eEF1c characterization as RPB3 protein
partner was intriguing and we started the analysis considering that
both bait ‘‘RPB3’’ and pray ‘‘eEF1c’’ appear extremely conserved
during evolution.
The bacterial alpha subunit homodimer directly interacts with
sigma factors enabling the specific binding of RNA polymerase to
gene promoters. The eukaryotic alpha subunit homodimer is
highly conserved and can be recognised in the two a-like RNA
polymerase II core subunits RPB3 and RPB11. In their precious
paper, Fan et al. (2010), described Drosophila eEF1c essential for
organismal and cellular viability [18], whereas the yeast eEF1c
orthologue has been defined as a non essential gene [31]. The
Biological General Repository for Interaction Datasets (Biogrid)
from yeast to human reveals a large number of potentially
interacting proteins for eEF1c, mostly of which are involved in
RNA metabolism, transcription regulation or mitochondrial
metabolism. Some genes of particular interest are the following:
yeast She2, a RNA-binding protein that is part of the mRNA
localisation machinery that restricts the accumulation of certain
proteins to the bud [32]; yeast Whi3, a RNA binding protein that
sequesters CLN3 mRNA in cytoplasmic foci [33]; TAF2, a TFIID
subunit involved in pol II transcription initiation; YSP1 (Yeast
Suicide Protein), a mitochondrial protein with a potential role in
promoting mitochondrial fragmentation during programmed cell
death [34]; human Med31, a component of the Mediator complex
and a co-activator involved in the regulated transcription of nearly
all pol II-dependent genes [35] and human Nup85, an essential
component of the nuclear pore complex involved in RNA export
[36]. We showed that the RPB3 and eEF1c proteins co-
immunoprecipitate when over-expressed in HeLa cells (and in
SY5Y cells; data not shown). To better understand the nature of
the RPB3/eEF1c interaction, we defined the RPB3 and eEF1c
protein regions responsible for reciprocal binding. The a-like-1
domain, a 62 amino acids region at the amino terminal of RPB3,
appears to be responsible for this interaction. This region is also in
charge to bind both RPB11, the second a-like pol II subunit [6,37–
38] and CCHCR1 which compartmentalises RPB3 in the cytosol
[10]. The observation that eEF1c requires the same region that
RPB3 uses to bind RPB11 inside the pol II enzyme is intriguing.
This finding opens the interesting possibility that eEF1c could be
an alternative to RPB11 in the pol II assembly. This issue will be a
focus of our future work. On eEF1c side, we defined a crucial
RPB3-interacting region 40 amino acid long between residue 137
to residue 177. This eEF1c region apparently does not share
homology with other proteins described to bind RPB3.
Taking into account that RPB3 protein exerts its crucial role in
the nucleus as part of the pol II core enzyme, we demonstrated
that eEF1c co-immunoprecipitates with the pol II enzyme. Fan et
al. (2010) showed that eEF1c is detectable in Drosophila pupal
nuclear extracts and we confirmed the presence of human eEF1c
in HeLa cell nuclear extracts [18]. Hax1, another Vimentin
mRNA binding protein, was also shown to be present in HeLa cell
nuclear extracts. Hax1 is a mitochondrial protein present also in
the cytosol and in the nucleus. Hax1 deficiency causes autosomal
recessive severe congenital neutropenia (SCN), or Kostmann
disease [39–40]. Hax1 is involved in signal transduction,
cytoskeletal control, mRNA transport and programmed cell death
and is critical to maintaining the inner mitochondrial membrane
potential [39,41]. Both Hax1 and eEF1c have the ability to bind
Vimentin mRNA and have similar cellular localisations. Based
upon the presence of eEF1c in the nuclear compartment, its ability
to bind RPB3 and pol II plus its aptitude to combine with
Vimentin mRNA we investigated the possibility that eEF1c could
also stay on the Vimentin gene promoter. Chromatin immuno-
precipitation (ChIP) experiments were used to examine the
Vimentin promoter region immediately adjacent to its transcrip-
tion start site. eEF1c appears to bind Vimentin promoter region in
both HeLa and SY5Y human cell lines. Based on a parallel
between eEF1c and Hax1 proteins, we also analyzed the promoter
region of the DNA-polb gene, whose mRNA is complexed with
Hax1 [42]. In our experimental conditions eEF1c did not bind
DNA polb gene promoter, whereas we demonstrate that eEF1c
binds the promoter region of the Che-1/AATF gene [43–44],
another pol II binding protein (data not shown). It emerges that
eEF1c controls Vimentin gene through different pathways. Al-
Maghrebi et al. (2002) showed that eEF1c and Hax1 proteins bind
the 39 untraslated region (39UTR) of Vimentin mRNA [22], while
Bermano et al. demonstrated that the 39UTR of Vimentin mRNA
is required for Vimentin RNA perinuclear localization [28].
Morris et al. (2000) elegantly demonstrated that misdirecting
Vimentin mRNA it is possible to alter cell morphology and
motility [25]. They demonstrated it replacing Vimentin 39UTR,
where the Hax1 and eEF1c binding sites are present, with b-actin
39-UTR. Here, we show that depletion of eEF1c by siRNA
induces Vimentin protein de-localisation, Vimentin appears to
accumulate along cell membrane and cellular shape comes out less
organized and thick. Vimentin is a member of the intermediate
filament family of proteins, it is important for obtaining cellular
cytoskeleton flexibility [45]. Vimentin also plays a significant role
in supporting and anchoring the position of the organelles in the
cytosol supporting mitochondrial morphology and organization
[26]. Following this rationale, we verified the presence of eEF1c
within mitochondria in human cells. We demonstrated its presence
in an enriched HeLa mitochondria extract using both Hax1 and
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recently shown to mediate the localisation of mRNAs to
mitochondria [46]. Indirect immunofluorescence also revealed
the partial mitochondrial co-localisation of eEF1c with both
Tom20 and the mitochondrion-selective dye, MitoTracker. To
further examine the potential role of eEF1c in mitochondrial
metabolism, mitochondria were examined after eEF1c depletion
by siRNA. Indirect immunofluorescence of Tom20 in HeLa and
SY5Y cells showed clear mitochondrial fragmentation, swelling
and disorganisation. This mitochondrial crisis is accompanied by a
dramatic increase in the levels of superoxide and a consistent
increase in the levels of carbonylated proteins. We tested the
impact of eEF1c depletion on Vimentin gene expression detecting
a slight decrease in mRNA level without any significant change in
protein level. In addition, we did not find any impact of eEF1c
depletion on global translation. These data are in agreement with
the finding that depletion of eEF1c in the yeast Saccharomices
cerevisiae results in resistance to oxidative stress without any
detectable alterations in total protein synthesis [14]. Moreover a
very recent work shows that Yeast strains lacking eEF1c
accumulate a greater amount of oxidized proteins which correlates
with changes in heat shock chaperones and altered vacuole
morphology [47]. All these data taken together consent to
speculate that eEF1c can be involved in stress response and that
its depletion impairs a proper cell reaction to specific stress events.
On the other hand, the role of eEF1c in translation is suggested
principally by its co-purification with the elongation factor-1
complex. Several studies concerning eEF1c function/s have as
common denominator a broader role of this protein in RNA and
protein metabolisms.
Our on going work is focused on isolation and characterization
of novel mRNAs bound to eEF1c protein. Here, we suggest that
eEF1c in addition to its role in translation elongation, participates
in governing specific genes in certain stress conditions by
contacting both pol II and gene promoters and then shuttling/
nursing mRNAs, as Vimentin mRNA, from a gene locus to their
appropriate cellular compartment for translation.
Supporting Information
Figure S1 A: eEF1c binds the Vimentin promoter at the
endogenous chromosomal site. Chromatin immuno-precipitation
was performed in human neuroblastoma SY5Y cell line using the
anti-eEF1c rabbit polyclonal antibody/protein G-agarose beads or
only protein G-agarose beads as a control (no-Ab). Immuno-
precipitates from each sample were analysed by PCR performed
using primers specific for the human Vimentin promoter. DNA-
pol b and thymidine kinase human promoters were also amplified.
A sample representing the linear amplification of the total input
chromatin (input) was included in the PCR as a control. B: Dual-
label immunofluorescence in HeLa cells to show the co-
immunolocalisation of endogenous eEF1c (green) and mitochon-
dria using the anti-eEF1c monoclonal antibody and the mito-
chondrion-selective dye MitoTracker (red). C: Indirect immuno-
fluorescence obtained with the anti-Tom20 rabbit polyclonal
antibody in SY5Y cells: treated with siRNA-Control or siRNA-
eEF1c. D: The global protein synthesis of SY5Y cells, transfected
with either siRNA-Control or siRNA-eEF1c and supplemented
with S35 labelled methionin and cystein, was visualized by
autoradiography of the total protein lysates blotted to nitrocellu-
lose membrane. Then the same membrane was incubated with the
anti-eEF1c rabbit polyclonal and the anti-Vimentin monoclonal
antibodies. Anti-b-actin monoclonal antibody was used to
normalise the amount of protein loaded on the gel. E: The
induced carbonylation pattern (oxidation level) of human
neuroblastoma SY5Y cell line treated with either siRNA-Control
or siRNA-eEF1c. The total protein carbonylation pattern was
visualised by western blot with the anti-DNP antibody. Depletion
of eEF1c by siRNA was monitored using the anti-eEF1c rabbit
polyclonal antibody. Vimentin protein level was monitored by
anti-Vimentin monoclonal antibody. Anti-alpha-tubulin monoclo-
nal antibody was used to normalise the amount of protein loaded
on the gel.
Found at: doi:10.1371/journal.pone.0014481.s001 (10.73 MB
TIF)
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